Kinnate

KNTE

KNTE Kinnate NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    KNTE Chart
    See on advanced chart >

    About

    Kinnate Biopharma Inc. is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The company's mission is to expand the reach of targeted therapeutics by...
    • Highlight
      A clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      12/03/2020
    • Established Date
      Invalid Date
    • Full-time Employees
      27
    • Address
      103 Montgomery Street Suite 150 The Presidio of San Francisco San Francisco CA 94129
    • Tel
      1-858-2994699
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock